Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells.

Schaeffer P, Nestor AL, Prabonnaud V, Bachy A, Laplace MC, Keane PE, Bignon E, Herbert JM.

Eur J Pharmacol. 2000 Jun 2;397(2-3):303-10.

PMID:
10844128
2.

Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex.

Labie C, Lafon C, Marmouget C, Saubusse P, Fournier J, Keane PE, Le Fur G, Soubrié P.

Br J Pharmacol. 1999 May;127(1):139-44.

3.

SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset.

Simiand J, Keane M, Keane PE, Soubrié P.

Behav Pharmacol. 1998 Mar;9(2):179-81.

PMID:
10065938
4.

The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse.

Duong F, Fournier J, Keane PE, Guénet JL, Soubrié P, Warter JM, Borg J, Poindron P.

Br J Pharmacol. 1998 Jun;124(4):811-7.

5.

The non-peptide neuroprotective agents SR 57746A interacts with neurotrophin 3 to induce differentiation in the PC12 cell-line.

Fournier J, Boutot G, Keane PE, Maffrand JP, Le Fur G, Soubrié P.

J Pharm Pharmacol. 1998 Mar;50(3):323-7.

PMID:
9600726
6.

Expression of cytokine genes during ontogenesis of the central nervous system.

Pousset F, Fournier J, Keane PE.

Ann N Y Acad Sci. 1997 Apr 24;814:97-107. Review. No abstract available.

PMID:
9160963
7.

Effect of SR 59026A, a new 5-HT(1A) receptor agonist, on sexual activity in male rats.

Arnone M, Baroni M, Gai J, Guzzi U, Desclaux MF, Keane PE, LeFur G, Soubrié P.

Behav Pharmacol. 1995 Apr;6(3):276-282.

PMID:
11224336
8.

Effects of the sigma receptor ligand SR 31742A on neurotensin biosynthesis in rat basal ganglia.

Labie C, Saubusse P, Keane PE, Le Fur G, Soubrié P.

Synapse. 1995 Apr;19(4):241-6.

PMID:
7792719
9.

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates.

Fournier J, Steinberg R, Gauthier T, Keane PE, Guzzi U, Coudé FX, Bougault I, Maffrand JP, Soubrié P, Le Fur G.

Neuroscience. 1993 Aug;55(3):629-41.

PMID:
8413926
10.

Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.

Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE, et al.

J Lipid Mediat. 1993 Aug;8(1):31-51.

PMID:
8257776
11.

The sigma receptor ligand SR 31742A increases neurotensin in the nucleus accumbens but not in the caudate-putamen of the rat.

Labie C, Keane PE, Soubrié P, Le Fur G.

Eur J Pharmacol. 1993 Feb 16;231(3):465-7.

PMID:
8095466
12.

Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist.

Bachy A, Steinberg R, Santucci V, Fournier M, Landi M, Hamon M, Manara L, Keane PE, Soubrié P, Le Fur G.

Fundam Clin Pharmacol. 1993;7(9):487-97.

PMID:
8314196
13.

Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.

Simiand J, Keane PE, Barnouin MC, Keane M, Soubrié P, Le Fur G.

Fundam Clin Pharmacol. 1993;7(8):413-27.

PMID:
7904976
14.

Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptors.

Simiand J, Keane PE, Guitard J, Langlois X, Gonalons N, Martin P, Bianchetti A, Le Fur G, Soubrié P.

Eur J Pharmacol. 1992 Aug 25;219(2):193-201.

PMID:
1358639
15.

Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.

Keane PE.

Pharm Weekbl Sci. 1992 Jun 19;14(3A):144-5. No abstract available.

PMID:
1354349
16.

Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells.

Larcher JC, Vayssiere JL, Le Marquer FJ, Cordeau LR, Keane PE, Bachy A, Gros F, Croizat BP.

Eur J Pharmacol. 1989 Feb 28;161(2-3):197-202.

PMID:
2542045
17.

Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants.

Simiand J, Keane PE, Biziere K, Soubrie P.

Arch Int Pharmacodyn Ther. 1989 Jan-Feb;297:272-85.

PMID:
2567153
19.
20.

The effects of general anaesthetics on GABAergic synaptic transmission.

Keane PE, Biziere K.

Life Sci. 1987 Sep 21;41(12):1437-48. Review. No abstract available.

PMID:
2887996
26.

Effect of valproate on brain GABA: comparison with various medium chain fatty acids.

Keane PE, Morre M.

Pharmacol Res Commun. 1985 Jun;17(6):547-55.

PMID:
3927325
27.
29.

The quinolines PK 8165 and PK 9084 possess benzodiazepine-like activity in vitro but not in vivo.

Keane PE, Simiand J, Morre M.

Neurosci Lett. 1984 Mar 9;45(1):89-93.

PMID:
6145125
30.

Valproate: recent findings and perspectives.

Morre M, Keane PE, Vernières JC, Simiand J, Roncucci R.

Epilepsia. 1984;25 Suppl 1:S5-9. No abstract available.

PMID:
6325141
31.

The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents.

Simiand J, Keane PE, Morre M.

Psychopharmacology (Berl). 1984;84(1):48-53.

PMID:
6149594
32.

The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice.

Keane PE, Simiand J, Mendes E, Santucci V, Morre M.

Neuropharmacology. 1983 Jul;22(7):875-9.

PMID:
6413882
33.

The effect of niaprazine on the turnover of 5-hydroxytryptamine in the rat brain.

Keane PE, Strolin Benedetti M, Dow J.

Neuropharmacology. 1982 Feb;21(2):163-9.

PMID:
6460945
34.

Mechanism of anticonvulsant action of valproate.

Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC.

Prog Neurobiol. 1982;19(4):315-59. Review. No abstract available.

PMID:
6134304
35.

The effect of monoamine oxidase A and B inhibitors on rat serum prolactin.

Keane PE, Menager J, Strolin Benedetti M.

Neuropharmacology. 1981 Dec;20(12A):1157-62. No abstract available.

PMID:
7322290
36.

Reduced accumulation in brain of orally ingested beta-phenethylamine after inhibition of type A monoamine oxidase in the rat.

Keane PE, Benedetti MS.

J Pharm Pharmacol. 1981 Dec;33(12):800-2. No abstract available.

PMID:
6121858
37.
38.

Differential changes in monoamine oxidase A and B activity in the aging rat brain.

Benedetti MS, Keane PE.

J Neurochem. 1980 Nov;35(5):1026-32.

PMID:
7452302
40.

Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.

Keane PE, Kan JP, Sontag N, Benedetti MS.

J Pharm Pharmacol. 1979 Nov;31(11):752-4.

PMID:
41906
41.

Niaprazine, a selective brain catecholamine depletor.

Keane PE, Benedetti MS.

Neuropharmacology. 1979 Jul;18(7):595-600. No abstract available.

PMID:
158713
42.
43.

The effect of acetylcholine and dopamine on the caudate spindle in cats.

Keane PE, Hall RC.

J Neurosci Res. 1977;3(3):209-16.

PMID:
615272
44.

The role of endogenous catecholamines in the regulation of electrocortical activity in the encephale isole cat.

Keane PE, Candy JM, Bradley PB.

Electroencephalogr Clin Neurophysiol. 1976 Dec;41(6):561-70.

PMID:
62650
45.

Supplemental Content

Loading ...
Support Center